Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Since the trade +66.9% · S&P 500 +22.8% · to Nov 19
A Neogen director paid $100K out of pocket for Neogen shares. 7 other people at Neogen bought some too, in the same month. Shares held went up 270% with this purchase.
Since the trade +108.7% · S&P 500 +30.9% · to Nov 19
A Neogen director paid $150K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 50% with this purchase.
Since the trade +110.3% · S&P 500 +30.0% · to Nov 19
A Neogen director paid $30K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 77% with this purchase.
Since the trade +108.7% · S&P 500 +30.9% · to Nov 19
A Neogen director paid $171K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 137% with this purchase.
Since the trade +108.7% · S&P 500 +30.9% · to Nov 19
A Neogen director paid $26K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 16% with this purchase.
Since the trade +120.5% · S&P 500 +33.7% · to Nov 19
Neogen's Chief Legal Officer paid $62K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 53% with this purchase.
Since the trade +128.4% · S&P 500 +35.8% · to Nov 19
A Neogen director paid $100K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 350% with this purchase.
Since the trade +128.4% · S&P 500 +35.8% · to Nov 19
A Neogen director paid $47K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 36% with this purchase.
Since the trade +128.4% · S&P 500 +35.8% · to Nov 19
A Neogen director paid $34K out of pocket for Neogen shares. 8 other people at Neogen bought some too, in the same month. Shares held went up 100% with this purchase.
Since the trade −6.5% · S&P 500 +21.0% · to Nov 19
The CFO of Neogen paid $164K out of pocket for Neogen shares. 1 other person at Neogen bought some too, in the same month. Shares held went up 32% with this purchase.
Since the trade −6.5% · S&P 500 +21.0% · to Nov 19
The CEO of Neogen paid $254K out of pocket for Neogen shares. 1 other person at Neogen bought some too, in the same month. Shares held went up 9% with this purchase.
1 open-market purchase and 1 open-market sale by insiders of NEOG between Dec 9, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 6, 2026. The data provider lists the next release for Jan 6, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Jeremy Yarwood, Chief Scientific Officer, Nov 4, 2026, about $115K. Sold 29 days after the company's previous earnings release on 2026-10-06Form 4
Mikheal Nassif, CEO, Oct 9, 2026, about $6K. Bought 3 days after the company's previous earnings release on 2026-10-06Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies